Fluanxol tablets and Depixol depot injections have different indications and are not interchangeable. New suicidal danger, mania, severe restlessness, fainting with palpitations, or fever with severe stiffness or confusion needs urgent assessment. Do not alter a depot schedule or use flupentixol for an unsupervised detox.
Flupentixol is a thioxanthene medicine with different uses depending on the formulation and country. In the UK, the low-strength Fluanxol tablets discussed here are licensed for symptomatic treatment of depression with or without anxiety. Depixol contains long-acting flupentixol decanoate and is used for schizophrenia and other psychoses. A reader should not transfer the indication, dose or stopping instructions from one product to the other.
Why the exact product matters
Flupentixol may also be spelled flupenthixol. The active medicine name is only part of the prescription: the salt, formulation, route and treatment goal matter. Low-strength tablets and an oily depot injection are not simply two convenient ways of receiving the same treatment. Their authorized uses and the pattern of exposure differ. [1] [2]
When a prescription changes or care moves between countries, ask the pharmacist to confirm the full product. Do not confuse flupentixol with fluphenazine or zuclopenthixol because the names resemble one another. These are different active medicines, not alternative spellings or interchangeable doses.
Fluanxol tablets and depression-related prescribing
The cited UK Fluanxol tablet information describes symptomatic treatment of depression with or without anxiety. This is a product-specific license, not a claim that flupentixol is a preferred treatment for every depressive disorder. The same label excludes severe depression requiring ECT or hospitalization and states that it is unsuitable in excitement or overactivity, including mania. [1]
Ask why it was selected, what benefit is expected and when the response will be reviewed. A history of unusually elevated mood, reduced need for sleep or markedly increased activity should be discussed before a mood-related prescription. New suicidal thoughts or significant deterioration needs prompt assessment rather than waiting for the medicine to have more time.
Depixol depot and psychosis treatment
The cited Depixol decanoate injection is licensed for schizophrenia and other psychoses, with use restricted to people stabilized on oral treatment. It is a continuing-care formulation, not a home treatment for sudden agitation. A long-acting injection may suit someone who prefers that delivery pattern, but the decision should reflect the person’s needs and treatment history. [2]
The goal may be fewer distressing psychotic experiences and more consistent functioning. Discuss preferences, previous adverse effects and practical access to injection appointments. An injection does not replace psychological therapy or social support, and it should not be selected solely because a person also has a substance-use problem.
How flupentixol works
Flupentixol acts at dopamine receptors, including D1 and D2 receptors. A description of its receptor activity does not establish that depression or psychosis is caused by a simple dopamine imbalance. Nor does it predict whether a particular person will find the medicine activating, sedating or difficult to tolerate. [2]
The meaningful test is the balance of observed benefit and harm. Keep the treatment goal specific enough to assess: clearer thinking, reduced distress, improved daily activity or relief of the symptoms actually discussed with the prescriber. A change in energy alone may not represent a complete response.
Activation, restlessness and sleep changes
Flupentixol is sometimes described as relatively activating, and the Fluanxol label specifically warns against use in excitable or agitated patients. Restlessness or insomnia after starting treatment should therefore not automatically be interpreted as a need for more medication. Akathisia, mood activation and the underlying condition may require different responses. [1]
Describe whether the problem is an inner urge to move, racing thoughts, unusually increased activity or simply difficulty falling asleep. Note when it began and whether another prescription changed. The clinician needs this detail before deciding whether the medicine is helping or contributing to the problem.
Depot appointments and concentration differences
Depixol products include different concentrations. The volume of an injection is not enough to identify the amount of medicine administered. Administration and any conversion between products must be handled by the clinical team. Keep the full product name, last injection date and next appointment in the medication record. [2]
Report new adverse effects before the next injection. Depot medicine remains relevant after administration, so a change of plan cannot immediately remove exposure. If an appointment is missed, contact the team instead of replacing the injection with spare tablets or requesting an early extra injection without assessment.
Assessment and ongoing monitoring
Review cardiac disease, fainting, seizures, Parkinson’s disease, liver or kidney impairment, glaucoma, urinary problems and previous reactions to antipsychotics. Ongoing antipsychotic monitoring includes weight, blood pressure, glucose or HbA1c, lipids, prolactin-related symptoms and movement assessment, with ECG testing where indicated. [1] [3]
Make responsibility explicit when the GP, psychiatrist and injection service share care. Who requests tests, receives results and arranges the next review? A completed blood test does not demonstrate that a movement problem or disabling fatigue has been addressed. Describe the practical effect of treatment as well as the laboratory findings.
Movement and hormonal effects
Flupentixol can cause tremor, stiffness, slowed movement, dystonia and akathisia. Tardive dyskinesia may cause involuntary movements that persist. Report changes promptly, especially new mouth or tongue movements. Painful throat or neck spasms with breathing or swallowing difficulty are urgent. The treatment for one movement reaction may be inappropriate for another. [2]
Prolactin-related problems can include breast changes, milk production, menstrual disruption and sexual difficulties. These concerns should be discussed without assuming they are unrelated to treatment. Record their timing and effect on relationships or quality of life. The clinician may need to assess other causes and consider whether the prescription remains suitable.
Cardiac, metabolic and other precautions
Flupentixol can prolong the QT interval. Heart disease, electrolyte problems and other QT-prolonging medicines can increase concern, so fainting with palpitations needs urgent assessment. Weight, appetite and glucose changes also require attention. New infection symptoms, significant visual problems or jaundice should be reported rather than left until a routine injection visit. [2]
Older adults may be more vulnerable to sedation, low blood pressure, confusion and temperature changes. Depixol is not licensed for dementia-related behavioral disturbance in the cited UK information. Pregnancy and breastfeeding require a specific treatment review; do not independently stop an effective psychiatric prescription because of a general online warning.
Interactions and everyday safety
Alcohol, opioid medicines and other sedating treatments can increase impairment. Other dopamine-blocking medicines can add movement effects, while anticholinergic medicines may worsen bowel, bladder or visual problems. Lithium combinations and medicines affecting heart rhythm also need professional review. Include nonprescription products and occasional medicines in the list. [2]
Do not drive when thinking, alertness, balance or vision is impaired. Tell surgical and dental teams about treatment, especially a recent depot injection that will not be visible among daily tablets. Ask a pharmacist to review new prescriptions before assuming that an unchanged psychiatric dose means the overall treatment is unchanged.
Addiction care and detox distinctions
Flupentixol is not a stand-alone alcohol or sedative detox treatment. The product information calls for caution in conditions predisposing to seizures, including alcohol withdrawal, and contraindicates use in depressed consciousness caused by substances such as alcohol or opioids. An apparently agitated person may need urgent medical assessment rather than another psychiatric dose. [1]
A person with psychosis and addiction may need both antipsychotic and addiction treatment. NICE does not recommend depot antipsychotics as a specific treatment for the combination itself. The formulation decision belongs to the psychosis care plan, while withdrawal, relapse prevention and overdose safety require their own measures. [4]
Stopping tablets versus stopping future injections
The Fluanxol tablet information advises gradual withdrawal because abrupt cessation can cause symptoms such as nausea, sweating, insomnia or movement disturbances. This is different from addiction. A planned reduction should account for the original symptoms, treatment duration and what has happened during previous changes. [1]
Depixol concentrations decline over weeks after an injection. Its label therefore does not describe stopping in the same way as an oral taper. Decisions about future injections still require a clinician-led plan and monitoring for recurrence or delayed effects. Do not invent a schedule by matching tablet reductions to injection intervals. [2]
Preparing for a change in service
Before travel, hospital discharge or transfer to another clinic, confirm the product, current instructions and named prescriber. Include the last depot administration and the next due appointment where relevant. Discuss what will happen if the usual product cannot be obtained; a supply problem is not a reason to substitute a similarly named medicine independently.
Bring a short record of sleep, mood, psychotic symptoms and unwanted effects to review. The medication-review checklist can help organize questions. Agree which changes need prompt contact and which can be discussed at the planned appointment.
Frequently asked questions
Is flupentixol an antidepressant or antipsychotic?
It is pharmacologically a thioxanthene antipsychotic, but the cited UK low-strength Fluanxol tablets have a depression-related indication. Depixol depot has a psychosis indication. The exact product and reason for prescribing must be identified.
Is a depot injection a treatment for sudden anxiety?
No. It is not a self-directed rescue treatment. Sudden severe distress, mania or intoxication requires assessment of the cause and an appropriate care setting.
Which symptoms are an emergency?
Fever with severe stiffness or confusion, a seizure, collapse, breathing difficulty, fainting with palpitations or immediate suicidal danger needs urgent medical help. Do not wait for the next scheduled injection or medication review.
